At Midas Wellness Hub, we believe in enhancing beauty from the inside out
Laboratory studies of the Nextida GC collagen ingredient show that it may boost GLP-1 production and lower blood sugar levels
doi 10.1056/nejmoa2032183 100 LevineISekhriSSchreiber-StainthorpWLockeBDelauOElhawaryMet al
The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
A growing body of literature shows that when GLP-1 receptor agonists are administered, there are decreased levels of pro-inflammatory cytokines that are normally seen in the pathogenesis of many inflammatory diseases
It is a non-surgical treatment, so there is no need for cuts or stitches